Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIPOMERSEN for Hypercholesterolaemia: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 23 adverse event reports in the FDA FAERS database where MIPOMERSEN was used for Hypercholesterolaemia.

Most Reported Side Effects for MIPOMERSEN

Side Effect Reports % Deaths Hosp.
Injection site pain 67 33.7% 1 4
Hepatic enzyme increased 48 24.1% 0 5
Injection site erythema 48 24.1% 1 3
Influenza like illness 36 18.1% 0 3
Injection site bruising 31 15.6% 0 3
Fatigue 26 13.1% 0 2
Nausea 24 12.1% 0 4
Injection site discolouration 23 11.6% 1 1
Injection site swelling 23 11.6% 0 0
Injection site rash 18 9.1% 0 0
Injection site reaction 17 8.5% 1 1
Myalgia 17 8.5% 0 3
Headache 16 8.0% 0 0
Injection site pruritus 15 7.5% 0 1
Drug dose omission 14 7.0% 1 1

Other Indications for MIPOMERSEN

Type iia hyperlipidaemia (138) Product used for unknown indication (13) Blood cholesterol increased (10)

Other Drugs Used for Hypercholesterolaemia

EVOLOCUMAB (23,505) ATORVASTATIN (5,615) ALIROCUMAB (4,924) SIMVASTATIN (3,010) ROSUVASTATIN (2,690) EZETIMIBE (1,589) PRAVASTATIN (764) INCLISIRAN (486) FENOFIBRATE (286) FLUVASTATIN (264)

Related Pages

MIPOMERSEN Full Profile All Hypercholesterolaemia Drugs MIPOMERSEN Demographics MIPOMERSEN Timeline